Cultured human corneal epithelial cells treated with thymosin beta4
How the study was set up
Cultured human corneal epithelial cells were studied with thymosin beta4 and inhibitors of the P2X7 receptor.
What the researchers measured
Cell proliferation, gap closure, extracellular ATP, intracellular calcium, and ERK phosphorylation were measured.
How to read this evidence
Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.
Results in context
The work proposes a mechanism for movement of corneal cells. Human cells in culture are not clinical evidence of eye healing in patients.
What this does not establish
Human-derived cells are not human treatment trials; this study does not establish a TB-500 eye treatment.
This collection includes related thymosin beta4 research. Parent or engineered peptide findings do not establish that a TB-500 fragment or a product sold under that name has the same effects.
Publication & source
Why this paper is included
The title focuses on thymosin beta4 or TB-500; parent-peptide findings do not establish TB-500 fragment effects.
Publication indexing
Journal Article · Research Support, Non-U.S. Gov't
Indexed subjects
Adenosine Triphosphate · Blotting, Western · Calcium · Cell Movement · Cell Proliferation · Cells, Cultured · Electrophoresis, Polyacrylamide Gel · Epithelium, Corneal · Flow Cytometry · Humans · Immunoblotting · MAP Kinase Signaling System · Receptors, Purinergic P2X7 · Signal Transduction · Thymosin · Thymosin beta(4)
Source checked
October 4, 2026. Years follow journal issues; online-first dates may differ.